Amgen teams up with Blythe Danner for Act 2 Reduce Fractures campaign
THOUSAND OAKS, Calif. — Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.
The drug maker said that to promote its Act 2 Reduce Fractures campaign, which is supported by American Bone Health, the Global Healthy Living Foundation and the Older Women’s League, the company has tapped award-winning actress Blythe Danner, who was diagnosed with the disease, to encourage women to learn of the risk factors and ways to improve their condition.
"One-in-2 women over age 50 will have an osteoporosis-related fracture in her lifetime," American Bone Health executive director Kathleen Cody said. "And many women don’t proactively work with their doctors to help manage the disease and understand the factors that may increase their risk for fractures. Our goal is to encourage women with postmenopausal osteoporosis at increased risk for fractures to take action and speak to their doctors to learn all they can about helping to strengthen their bones."
Click here for more information.
Hi-Tech’s ECR subsidiary to market two acquired products
AMITYVILLE, N.Y. — Hi-Tech Pharmacal has acquired marketing and distribution rights for a product designed to treat coughs and upper respiratory symptoms associated with an allergy or a cold.
The generic drug maker said it attained rights for TussiCaps, available in 10-mg/8-mg and 5-mg/4-mg formulations, from Mallinckrodt. Hi-Tech’s ECR Pharmaceuticals subsidiary, which markets branded prescription products, will promote TussiCaps, the only extended-release prescription cough-cold capsule product approved by the Food and Drug Administration.
In related news, Hi-Tech also recently acquired the marketing and distribution rights to an abbreviated new drug application filing from KVK-Tech for an antihistamine/decongestant product — dexbrompheniramine maleate 6-mg/pseudoephedrine sulfate 120-mg extended release tablets — which will be marketed by ECR under the brand name Lodrane.
Walgreens elevating presence in Empire State
NEW YORK — Walgreens has renewed its lease on the ground floor of the Empire State Building, and exchanged 10,000 sq. ft. of retail space on the concourse level to 10,000 sq. ft. on the second floor near the observatory exit elevators, according to a report published by REBusiness Online Thursday.
"The all-glass second-floor store is slated for a first quarter 2012 completion," the report stated. Walgreens’ lease in the Empire State Building is for a 15-year term and totals 18,818 sq. ft.